Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
ALLOB cells with ceramic scaffold · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| ALLOB® cells with ceramic scaffold | EXPERIMENTAL | ALLOB® cells with ceramic scaffold Implantation |
| Name | Type | Description |
|---|---|---|
| ALLOB® cells with ceramic scaffold | DRUG | Each patient will undergo a single administration of ALLOB®/ceramic scaffold mix into the lumbar interbody fusion site under anaesthesia |
Inclusion Criteria: * Ability to provide a written, dated, and signed informed consent prior to any study related procedure, and to understand and comply with study requirements * Symptomatic degenerative disc disease of the lumbar spine requiring a single level lumbar fusion (L1-S1) * Unresponsive...
| Company | Ticker | Trials | Lead Phase | Drugs |
|---|---|---|---|---|
| Mesoblast Limited Sponsored ADR | MESO | 1 | PHASE3 | Rexlemestrocel-L, HA mixture, Saline |
| Creative Medical Technology Holdings, Inc. | CELZ | 1 | PHASE1 | CELZ-201-DDT |
| Stryker Corporation | SYK | 2 | N/A | Undisclosed |
| Globus Medical Inc Class A | GMED | 6 | - | Undisclosed |
| Orthofix Medical, Inc. | OFIX | 1 | - | Undisclosed |
ALLOB cells with ceramic scaffold is an investigational cell therapy being studied for the treatment of Degenerative Disc Disease. It is currently in Phase 2 clinical development and has not been approved by regulatory authorities.
ALLOB cells with ceramic scaffold is being developed by Bone Biologics Corp, a company listed on the NASDAQ under the ticker symbol BBLG.
ALLOB cells with ceramic scaffold is in Phase 2 clinical development. It is an investigational therapy and has not yet received regulatory approval for any indication.
ALLOB cells with ceramic scaffold has one completed clinical trial, NCT02205138, a Phase 2a study on allogeneic osteoblastic cells implantation in lumbar spinal fusion. The trial enrolled 38 participants with Degenerative Disc Disease in Belgium.
ALLOB cells with ceramic scaffold is a cell therapy that uses allogeneic osteoblastic cells, which are bone-forming cells, combined with a ceramic scaffold. It is being studied for its potential to promote bone formation in lumbar spinal fusion for Degenerative Disc Disease.